Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis.
Curry N, Davenport R, Thomas H, Fox E, Lucas J, Evans A, Massou E, Sharma R, Shanmugaranjan S, Rourke C, Newton A, Deary A, Dallas N, Fitzpatrick-Creamer C, Podbielski JM, Wade CE, Edwards A, Benger J, Morris S, Cotton BA, Piercy J, Green L, Brohi K, Stanworth S.
Curry N, et al. Among authors: wade ce.
Health Technol Assess. 2024 Nov;28(76):1-69. doi: 10.3310/JYTR6938.
Health Technol Assess. 2024.
PMID: 39545850
Free article.
Clinical Trial.